Patients with certain GLP1R variants may experience stronger appetite suppression at lower doses, suggesting earlier morning timing could prevent excessive nausea, while others may benefit from slightly higher doses timed strategically around their peak hunger windows
Boosts Skin Health: Supports skin cell rejuvenation, which can lead to improved skin texture and reduced signs of aging
It was submitted for regulatory approval in 2025, and results from the OASIS 4 clinical trials showed weight loss of around 13.6%, which is comparable to the injectable version
Choosing the right one involves thinking not just about initial weight loss but about long-term tolerability, cost sustainability, and availability
This means it mimics two different natural hormones in the body: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
How does this apply if I am also taking berberine or other supplements